OctoPlus N.V. has signed a Master Service Agreement with Sanofi. This agreement follows an ongoing collaboration for the development of a number of formulations. Further details on the compound and activities are not disclosed.   Mr. Jan Egberts, chief executive officer of OctoPlus, said, “We are proud of the confidence Sanofi has shown in our organization by signing this agreement. It reflects the success of our scientists and engineers who continuously develop new formulations and formul...